Introduction
============

Shiga toxin-producing *Escherichia coli* (STEC) represents an emerging group of zoonotic pathogens causing diarrhea, hemorrhagic colitis (HC), and the life-threatening hemolytic uremic syndrome (HUS) in humans ([@B35]). Strains of O157 serogroup have been considered to be most virulent, and STEC O157 strains have been extensively studied and shown to be involved in many cases and outbreaks of human disease ([@B13]; [@B17]; [@B34]; [@B19]). However, there is growing concern over the emergence of more than 200 non-O157 STEC serotypes associated with human illness, including the life threatening HUS ([@B12]). In fact, non-O157 strains are responsible for a larger portion of STEC infections than O157 strains in the United States, Canada, Australia, Latin America, and Europe ([@B24]; [@B6]; [@B39]; [@B5]). At present, detection methods and in depth studies are mainly focused on O157:H7 and the top six serogroups of STEC (O26, O45, O103, O111, O121, and O145) ([@B10]; [@B42]), thus the public health significance of STEC of other serotypes is likely to be underestimated due to the high diversity of genotypes and phenotypes.

Shiga toxin (Stx) is the most critical virulence factor of STEC, consisting of two broad immunologically different types: Stx1 with three subtypes (Stx1a, Stx1c, and Stx1d) and Stx2 with seven subtypes (Stx2a to Stx2g). Stx can damage intestinal epithelial cells and kidneys, causing HC and HUS ([@B35]). However, many non-O157 strains that produce Shiga toxin have been not associated with HUS cases, indicating additional virulence determinants may play a role in pathogenesis. Following initial attachment of STEC to host intestinal cells, strains that express intimin can intimately attach to host cells and cause the attaching-and-effacing lesion ([@B15]). Intimin is encoded by *eae* that resides on a chromosomal pathogenicity island called the locus of enterocyte effacement (LEE). Enterohemolysin (EhxA), encoded by a 60-MDa virulence plasmid in some STEC strains, that readily causes hemolysis of washed sheep erythrocytes, is another important virulence factor that contributes to severe disease in humans ([@B11]). A number of other adherence structures and virulence factors have also been proposed to contribute to STEC pathogenesis ([@B12]; [@B40]; [@B8]).

Though the main reservoir of STEC is the intestinal tract of cattle, many other domestic and wild animals including pig, sheep, dog, deer, wild boar, and hare are also sources of STEC ([@B29]; [@B28]; [@B31]; [@B3]; [@B33]). STEC strains have been described recently in diarrheal patients, domestic animals and foodstuffs of animal origin in China ([@B45]; [@B7]; [@B26]; [@B1]; [@B41]; [@B47]), but little data is available concerning wildlife. The plateau pikas (*Ochotona curzoniae*) are underground-dwelling mammals (order Lagomorpha) mostly living in the extremely harsh wild environments of severe cold, low atmospheric oxygen and strong ultraviolet radiation of the Qinghai-Tibetan plateau, China. Plateau pikas have close contact with yaks. In our previous study, we explored the occurrence and characteristics of STEC in yaks (*Bos grunniens*) for the first time, revealing that yaks are natural reservoirs of STEC, and some of the STEC strains they harbored had the potential to cause human disease ([@B2]). In this study, we investigated the prevalence of STEC in plateau pikas in this unique ecosystem.

Materials and Methods {#s1}
=====================

Collection of Samples
---------------------

Four sites were enrolled in this study in Yushu tibetan autonomous prefecture, Qinghai province, China, including Guoqinggou \[3,929 m above msl (mean sea level), latitude of 33°7′ and longitude of 96°84′), Jielachong (3,970 m above msl, latitude of 33°48′ and longitude of 96°51′), Gandacun (4,322 m above msl, latitude of 33°13′ and longitude of 96°73′), Batangtan (3,987 m above msl, latitude of 32°51′ and longitude of 96°56′)\]. The plateau pikas were captured by 'mousetrap' in their breeding seasons from May to August when their population densities are high, and the colon contents were collected. Fresh feces were picked up from the holes. In total, 1116 samples were collected consisting of 294 colon contents samples, 317 fecal samples, and 505 colon contents samples in the years 2012, 2013, and 2015, respectively. Samples were mixed in Luria-Bertani medium containing 30% glycerol (Land Bridge, Beijing, China), stored at -20°C immediately, and transported to the laboratory in National Institute for Communicable Disease Control and Prevention, China CDC, in ice cold conditions for the screening of STEC.

Isolation of STEC
-----------------

One gram of each sample was enriched into 5 ml of *E. coli* broth (Land Bridge, Beijing, China) and incubated at 37°C for 18 to 24 h with shaking at 200 rpm. The enriched samples were investigated for *stx*~1~ and *stx*~2~ genes by duplex PCR assay as used in our previous study ([@B1]). Briefly, 1.5 ml of each enrichment sample was centrifuged at 13,000 × *g* for 2 min, the pellet was suspended in 150 μl of lysis buffer (100 mM NaCl, 10 mM Tris-HCl \[pH 8.3\], 1 mM EDTA \[pH 9.0\], 1% Triton X-100), then boiled for 10 min, and centrifuged at 13,000 × *g* for 2 min. The supernatant was then used as the PCR template. Enriched samples that tested positive for *stx*~1~ and/or *stx*~2~ genes were plated onto CHROMagar^TM^ ECC agar (CHROMagar, Paris, France), and MacConkey agar (Oxoid, Hampshire, UK) and then incubated at 37°C overnight. About 10 colonies (blue or colorless, round moist *E. coli*-like colonies) on CHROMagar^TM^ ECC and 5 pink or red colonies on MacConkey were picked to screened for the presence of *stx*~1~ and/or *stx*~2~ genes by single colony duplex PCR assay ([@B1]). If all colonies were negative for *stx*, another 10 and 5 colonies on the two plates were picked and screened. Finally, with the exception of different colony colors (blue or colorless), *stx* types or *stx* combinations present in the same sample, only one STEC isolate from each *stx*-positive sample was kept for further identification as described previously ([@B1]).

Biochemical Tests and Serotyping of STEC Isolates
-------------------------------------------------

Each *stx*-positive isolate was confirmed to be *E. coli* by biochemical identification using the API 20E system (bioMérieux, Marcy l'Etoile, France). The O serogroup was determined using all available *E. coli* antisera, i.e., O1--O188 (Statens Serum Institut, Hillerød, Denmark). The entire coding sequence of *fliC* was amplified by PCR using primers F-FLIC1 (5′-ATGGCACAAGTCATTAATACCCAAC-3′) and R-FLIC2 (5′-CTAACCCTGCAGCAGAGACA-3′), as reported by [@B14], then sequenced and compared to a publicly available CGE SerotypeFinder web tool^[1](#fn01){ref-type="fn"}^ to determine the H type of each isolate ([@B22]).

*stx* Subtyping
---------------

The *stx*~1~ subtypes of STEC isolates were determined by a PCR-based subtyping method devised by [@B32]. The complete *stx*~2~ gene was amplified as described by [@B20], then cloned into vector pMD18-T and transformed into *E. coli* JM109 (Takara, Dalian, China). About 10 transformants were selected for sequencing to discern multiple *stx*~2~ subtypes in a PCR product. A neighbor-joining tree was constructed using MEGA 6 ([@B38]) to assign the *stx*~2~ subtype ([@B32]).

All *stx*~2~ nucleotide sequences determined in this study have been submitted to GenBank under accession numbers KU158844-KU158861.

Detection of Virulence and Adherence Factors
--------------------------------------------

Shiga toxin-producing *Escherichia coli* isolates were subjected to PCR for detection of intimin-encoding gene (*eae*), putative adhesin genes (*iha*, *efa1*, *saa*, *paa*, *eibG*), virulence-associated genes (*ehxA*, *katP*, *toxB*, *astA*, *subA*), the high-pathogenicity island (HPI) marker genes (*irp2* and *fyuA*) and 11 non-LEE encoded effector (*nle*) genes (*ent*, *nleA*, *nleB*, *nleB2*, *nleE*, *nleH1-1*, *nleH1-2*, *nleC*, *nleD*, *nleF*, *nleG*) using primers listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}.

Antimicrobial Susceptibility Testing
------------------------------------

Antimicrobial drug susceptibility was determined by the disk diffusion method as recommended by the Clinical and Laboratory Standards Institute ([@B9]). We tested the following 23 antimicrobial agents: penicillin G, amoxicillin/clavulanic acid, ampicillin/sulbactam, levofloxacin, nitrofurantoin, aztreonam, norfloxacin, chloramphenicol, cefepime, cephalothin, meropenem, ceftria xone, imipenem, streptomycin, ciprofloxacin, gentamicin, piperacillin, cefotaxime, nalidixic acid, kanamycin, trimethoprim-sulfamethoxazole, cefuroxime, and tetracycline (Oxoid, Hampshire, UK). Results were used to classify isolates as being resistant or susceptible to a particular antibiotic using standard reference values ([@B9]).

Pulsed-Field Gel Electrophoresis (PFGE)
---------------------------------------

Shiga toxin-producing *Escherichia coli* isolates were digested with *Xba*I and separated by pulsed-field gel electrophoresis (PFGE) according to the protocol for non-O157 STEC from PulseNet, USA^[2](#fn02){ref-type="fn"}^. Gel images were captured with a Gel Doc^TM^ XR+ system (Bio-Rad, Hercules, CA, USA). An UPGMA (unweighted pair-group method with arithmetic mean) dendrogram was constructed using BioNumerics software version 4.0 (Applied Maths, Sint-Martens-Latem, Belgium).

Multi-locus Sequence Typing (MLST)
----------------------------------

All STEC isolates were analyzed by multi-locus sequence typing (MLST) according to the *E. coli* MLST website^[3](#fn03){ref-type="fn"}^. Sequences types (STs) of the HUSEC (HUS-associated enterohemorrhagic *E. coli*) collection were obtained from <http://campus.uni-muenster.de/hyg_klhus_husec.html?&L~=~1> ([@B25]). All human STEC STs of O157 and the top six serogroups were obtained from the *E. coli* MLST website. A minimum spanning tree based on these STs was generated using BioNumerics software.

Statistical Analysis
--------------------

The χ^2^ test was performed using SAS software version 9.1 (SAS Institute Inc., Cary, NC, USA). *P* \< 0.05 was considered statistically significant.

Ethics Statement
----------------

The pikas in this study were captured by 'mousetrap' by local center for disease control and prevention for communicable diseases surveillance. The study was approved by the ethics committee of National Institute for Communicable Disease Control and Prevention, China CDC, according to the medical research regulations of National Health and Family Planning Commission of the People's Republic of China.

Results
=======

Prevalence of STEC in Plateau Pika Samples
------------------------------------------

Twenty-two STEC isolates were obtained from 21 of the 58 *stx*-positive plateau pika samples giving a culture positive rate of 36.21% for *stx*-positive samples and 1.88% for all samples (**Table [1](#T1){ref-type="table"}**). Single isolate was obtained from 19 intestinal content samples and one fecal sample. Two isolates (15ST443 and 15ST444) with different *stx* types were recovered from one intestinal contents sample collected in 2015. Nine out of 294 intestinal contents samples collected in 2012, one out of 317 fecal samples collected in 2013, and 11 out of 505 intestinal contents samples yielded STEC isolates, giving culture positive rates of 3.06, 0.32, and 2.18% for all samples, respectively (**Table [1](#T1){ref-type="table"}**). The culture positive rates in intestinal contents were much higher than that in feces (*P* \< 0.05).

###### 

Prevalence of Shiga toxin-producing *Escherichia coli* in plateau pika.

  Year    Type of sample       Number of samples   Number of *stx* positive (%)   Number of samples with STEC isolates (%)   Number of STEC isolates (%)
  ------- -------------------- ------------------- ------------------------------ ------------------------------------------ -----------------------------
  2012    Intestine contents   294                 10 (3.40)                      9 (3.06)                                   9 (3.06)
  2013    Feces                317                 2 (0.63)                       1 (0.32)                                   1 (0.32)
  2015    Intestine contents   505                 46 (9.11)                      11 (2.18)                                  12 (2.38)
  Total                        1116                58 (5.20)                      21 (1.88)                                  22 (1.99)

Serogroups and Serotypes
------------------------

In total, 13 different O serogroups and 7 different H types were identified among the 22 STEC isolates, which belonged to 14 serotypes: O2:H45, O8:H2, O8:H16, O49:H21, O74:H8, O81:H21, O82:H19, O96:H8, O119:H19, O120:H9, O159:H21, O163:H19, O169:H8, and O170:H8. The predominant serotypes were O8:H2, O2:H45, O74:H8, and O49:H21 of which we found four (18.18%), three (13.64%), three (13.64%) and two (9.09%) isolates, respectively. The remaining 10 serotypes were each represented by only one isolate (**Figure [1](#F1){ref-type="fig"}**).

![**Pulsed-field gel electrophoresis (PFGE) profiles of 22 non-O157 Shiga toxin-producing *Escherichia coli* (STEC) isolates from plateau pikas.** The corresponding isolate names, PFGE patterns, sequence types (STs), serotypes, *stx*~1~ and *stx*~2~ subtypes, the profiles of *ehxA*, *iha*, *saa*, *subA*, and *astA* genes, and antibiotic resistances are listed on the right. Year of sampling is contained in the first two numbers of the isolate names: 12 means year 2012, 13 means 2013, and 15 means 2015. Abbreviations for antibiotics are: S, Streptomycin; KF, Cephalothin. '+' means genes positive or antibiotic resistant; '-' means genes negative or antibiotic susceptible.](fmicb-07-00375-g001){#F1}

Presence of *stx* Genes and *stx* Subtypes and Other Virulence Factor Genes
---------------------------------------------------------------------------

Among the 22 STEC isolates, five tested positive for *stx*~1~ only, 14 for *stx*~2~ only, and three for both *stx*~1~ and *stx*~2~. All of the eight *stx*~1~ were subtyped into *stx*~1a~. Of the 17 *stx*~2~-positive STEC isolates, one was subtyped into *stx*~2a~, five were *stx*~2b~, 10 were *stx*~2d~, and one isolate carried both *stx*~2a~ and *stx*~2d~ (**Figure [1](#F1){ref-type="fig"}**).

All 22 STEC isolates were *eae* negative. Of the five other putative adhesin genes (*iha*, *saa*, *efa1*, *paa*, *eibG*) screened, *iha* and *saa* were present in 16 (72.73%) and 15 (68.18%) isolates, respectively, and the 15 *saa* positive STEC isolates also carried *iha*. The other three adhesin genes were not detected in any of the 22 isolates. We also screened five virulence-associated genes (*ehxA*, *katP*, *toxB*, *astA*, *subA*), two markers for HPI (*irp2* and *fyuA*), and 11 non-LEE encoded effector (*nle*) genes. Fifteen (68.18%) STEC isolates were positive for *ehxA*, fourteen (63.64%) and three (13.64%) were positive for *subA* and *astA*, respectively. All our STEC isolates were negative for *katP*, *toxB*, the HPI genes and the 11 *nle* genes (**Figure [1](#F1){ref-type="fig"}**).

Antibiotic Resistance
---------------------

Antimicrobial resistance was determined using 23 antibiotics. All 22 STEC isolates were resistant to penicillin G. Four and one isolates were resistant to cephalothin and streptomycin, respectively, giving resistance rates of 18.18 and 4.55%. All isolates were susceptible to the remaining 20 antibiotics (**Figure [1](#F1){ref-type="fig"}**).

Pulsed-Field Gel Electrophoresis (PFGE)
---------------------------------------

The 22 non-O157 STEC isolates were analyzed by PFGE to investigate their genetic relationships. All isolates produced clear bands, and could be divided into 16 PFGE patterns (EMSX11001 to EMSX11016). An UPGMA dendrogram showed that the STEC isolates were genetically diverse with nodes linking isolates at less than 90% similarity (**Figure [1](#F1){ref-type="fig"}**). Four isolates (12ST452, 12ST453, 12ST454, 12ST459) from intestinal contents collected in 2012, two isolates (15ST441, 15ST444) from intestinal contents collected in 2015, and three isolates (12ST456, 15ST442, and 15ST447) from intestinal contents collected in different years (two in 2015 and one in 2012) showed identical PFGE patterns, sequence type, serotype and virulence gene profile. The two isolates (15ST443, 15ST444) obtained from a single intestinal contents sample showed different PFGE patterns, serotypes and virulence gene profiles (**Figure [1](#F1){ref-type="fig"}**).

Multi-locus Sequence Typing (MLST)
----------------------------------

A total of 12 different sequence types (STs) were identified among the 22 STEC isolates, including one novel sequence type, ST5741, resulting from a novel allele type, *icd* 592. ST1001 was the most frequent ST, represented by four isolates with identical PFGE pattern, serotype, virulence gene profile and antibiotic resistance pattern. Three STs (ST297, ST906, and ST3692) were represented by three isolates each. Among these, the ST297 isolates showed different PFGE patterns, serotypes and *stx* profiles; ST906 isolates demonstrated different PFGE patterns and *stx* profiles; while ST3692 isolates exhibited an identical PFGE pattern, serotype, virulence gene profile and antibiotic resistance pattern. ST40 was detected in two isolates with different resistance patterns, and the other seven STs were found only once. There is a good concordance between MLST and PFGE; isolates of the same ST generally showed the same or similar PFGE patterns (**Figure [1](#F1){ref-type="fig"}**).

Discussion
==========

The Qinghai-Tibetan plateau is a region where the altitude is high, the temperature is low and ultraviolet radiation is strong. Plateau pikas (*O. curzoniae*) play important roles in this ecosystem, such as recycling nutrients in soil, providing food to predators, and providing microhabitats by increasing plant richness, while their burrows provide nests for small birds and reptiles ([@B46]). Plateau pikas have been proved to be a reservoir of some pathogens ([@B49]; [@B48]). In the current research, we found that 5.2% (58/1116) of the plateau pika samples were positive for the *stx* genes by PCR and 1.88% (21/1116) by microbiological culture. The prevalence of STEC in plateau pikas is much lower than that in yaks from the same geographical region ([@B2]), where 11.68% (85/728) of samples yielded STEC strains. Notably, more than 60% of the *stx*-positive samples by PCR were negative by culture in this study. It was inferred that several factors may result in the failure to isolate STEC from the *stx*-positive samples, such as the low levels of STEC in the samples, the perturbation of high levels of background microflora, the presence of other bacteria carrying *stx*, the interference of free Stx phages ([@B30]). Different STEC isolation methods may also contribute to the recovery of different serotype strains ([@B23]) and dual plating on lesser and more highly selective agars may maximize the recovery of target STEC strains ([@B18]). A possible reason for no isolation of STEC O157 and the top six non-O157 STEC strains might be the method used. In this study, we used CHROMagar^TM^ ECC and MacConkey agars and didn't specifically target O157 or the top six serogroups. For instance, use of O157 or the top six serogruops specific immunomagnetic beads to capture the bacteria from enrichment broth with subsequent culture in selective media are required in further study to improve the isolation of these strains. Notably, STEC were similarly distributed in intestine content samples collected in the years 2012 and 2015, while the prevalence in feces was much lower, according with observations on swine STEC strains in our previous study ([@B26]).

The STEC isolates from plateau pikas were highly genetically diverse, revealed by serotyping, PFGE, MLST, and virulence gene profiles. Isolates from different samples collected in the same or different years (four isolates from year 2012, two isolates from 2015, and three isolates from 2012 and 2015) had an identical PFGE pattern, sequence type, serotype and virulence gene profile, implying some STEC clones may be widespread and persistent in this region. STEC isolates 15ST443 and 15ST444 obtained from the same intestinal contents sample showed different PFGE patterns, serotypes and virulence gene profiles, indicating that some plateau pikas could be colonized by more than one STEC clone.

The predominant serotypes O8:H2 and O2:H45 were also observed in yak STEC isolates, and O2:H45 was the most common serotype among yak isolates ([@B2]). Nine sequence types (ST40, ST297, ST737, ST906, ST1001, ST3686, ST3692, ST3883, and ST3884) were identified in STEC from both yaks ([@B37]) and plateau pikas, suggesting some STEC strains may be widely spread among animals in the same geographical region; however, the transmission route remains to be understood. Resistance to multiple antimicrobials has been shown in many non-O157 STEC isolates from humans, animals and food ([@B36]). [@B44] supported the theory that antibiotics play an important role in the progression of HUS and therefore the resistances of STEC may have relevance to clinical symptoms. In the present study, 20 of the 23 antimicrobial agents were active against all 22 plateau pika STEC isolates, the exceptions being penicillin G, cephalothin and streptomycin. These results were quite different from those observed in healthy pigs in China, where only two of the 23 antimicrobial agents (imipenem and meropenem) were active against all the STEC isolates ([@B26]). The lower antibiotic resistance may due to a low prevalence of drug resistant bacteria in this ecosystem.

Shiga toxin (Stx) production, especially Stx1a, Stx2a, Stx2c, and Stx2d, has been implicated in causing severe disease and HUS, and STEC carrying Stx2b are mainly associated with diarrheal disease ([@B16]; [@B21]; [@B4]). Adherence to the intestinal epithelium and subsequent colonization are crucial for the STEC pathogenic process. STEC isolates that carry both *stx*~2~ and *eae* genes are often associated with severe disease ([@B43]). [@B12] reported that non-LEE encoded effector (*nle*) genes are correlated with outbreak and HUS potential in humans. In the present study, different profiles, i.e., *stx*~1a~, *stx*~2a~, *stx*~2b~, *stx*~2d~, *stx*~1a~ + *stx*~2d~, and *stx*~2a~ + *stx*~2d~, were present in the 22 non-O157 STEC isolates, but all were *eae* negative. Some of the isolates carried virulence genes *ehxA* (68.18%), *subA* (63.64%), *astA* (13.64%), or adherence genes *iha* (72.23%) and *saa* (68.18%). Other novel virulence or adherence factors in these STEC isolates besides *stx* need to be further investigated. Multi-locus sequence typing identified 12 STs obtained in this study. The 32 STs of the HUSEC collection and 36 human STEC STs from the *E. coli* MLST database were considered to assess the potential risk of human infection by plateau pika STEC strains. None of the STs of plateau pika STEC were identical to any of the human STEC STs. Only one, ST40, with two isolates (15ST441 and 15ST444), was also observed in the HUSEC collection (**Figure [2](#F2){ref-type="fig"}**), but these two isolates harbored the low-virulence *stx*~2b~ gene and no other virulence genes were detected. These data suggest that STEC in plateau pikas may have low potential to cause human disease.

![**Minimum spanning tree of 12 STs from this study (blue), 32 STs from the HUSEC collection (red), and 36 STs from human STEC STs of serogroups O26, O45, O103, O111, O121, O145, and O157 in the *E. coli* MLST database (green).** Each circle represents a ST, with the pie divided proportionally to the number of isolates in that ST from different sources. The number in a circle indicates the ST number. The numbers on connecting lines represent the number of allelic differences between two STs.](fmicb-07-00375-g002){#F2}

In China, STEC O157 strains were detected in different animals and caused a major outbreak in 1999 ([@B45]; [@B27]). Non-O157 STEC strains have been isolated from different animals and raw meats in China as reported in our previous studies ([@B2], [@B1]; [@B26]). In recent years, STEC isolates including O157 and non-O157 serogroups have been reported in diarrheal patient by several other studies in China ([@B7]; [@B41]; [@B47]), but limited information is available regarding the phenotypic and genetic characteristics of these STEC isolates. Thus, further indepth studies on STECs from different resources in China are required to determine their pathogenic potential.

Conclusion
==========

We initially revealed that plateau pikas may be a natural reservoir of STEC, extending our knowledge of the genetic diversity and reservoir host range of STEC. Based on comparison by serotypes and MLST analysis with human strains and presence of virulence genes, the majority of these pika STECs may have a low potential to cause human disease. However, further investigations are needed to assess the public health significance in Tibetans and nomadic pastoralists in this geographic region.
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